Dr. Subir Ray

Dr. Subir Ray
Endocrinologist, Kolkata

MBBS, MD, MRCP, FRCP, Specialist Certificate in Diabetes & Endocrinology(UK)

Dr. Subir Ray is a Consultant in Endocrinology practicing at Apollo Gleneagles Hospitals,Kolkata which is a 350-bedded super specialty tertiary care center.
  • Languages :Bengali, English, Hindi

Specialities

  • Endocrinology

Expertise

Management of diabetes and hormonal disorders.

Education

  • MB BS. MD. MRCP (UK). FRCP(Edinburgh).Specialist Certificate in Endocrinology & Diabetes (Royal Colleges of Physicians, UK)

Practice Information

Apollo Gleneagles Hospital, Kolkata

Apollo Gleneagles Hospital, Kolkata

Near Saltlake Stadium, No. 58, Canal Circular Road, Kolkata, West Bengal - 700054

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Subir Ray and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes.(Sanjay Chatterjee1, Anirban Majumder2, Subir Ray3 –Nature Scientific Reports.January 2015)
  • Effect of Saroglitazar on Metabolic Parameters in Indian Patients with Diabetic Dyslipidemia - A 40 week, Retrospective Analysis -Author Block: SANJAY CHATTERJEE, ANIRBAN MAJUMDER, SUBIR RAY, Kolkata, India (Abstract ADA 2016)
  • Assessment of Glycemic control in patients of Diabetes Mellitus on insulin therapy- JJ Mukherjee, Sujoy Majumdar & Subir Ray –Journal of Indian Medical Association (JIMA) November, 2013 pp761-765
  • Diabetes and Pheochromocytoma (Diapidia,the online journal of diabetes.)
  • Diabetes in primary aldosteronism-( Diapidia,the online journal of diabetes)
  • An audit of adrenal incidentaloma-(Abstract British Endocrine Society Annual Spring Conference 2006) John Chapman, Subir Ray & Isha Malik  . Sunderland Royal Hospital, Sunderland, United Kingdom
  • Pre-operation imaging of parathyroid gland in primary hyperparathyroidism (Abstract BES 2008)-Isha Malik, John Chapman & Subir Ray .City Hospitals of Sunderland NHS Trust, Sunderland, UK. 
  • Unhappy doctors-Are we overreacting? (e-BMJ ,June 2002)
  • He has written more than 50 articles in leading newspapers and journals. He has written multiple book chapters and he is an active contributing author of Diapedia,the online textbook of diabetes.
  • Effects on metabolic parameters of addition of SGLT‐2 inhibitors on patients with type 2iabetes inadequately controlled with dpp‐iv inhibitors and metformin.Sanjay Chatterjee1, Anirban Majumder2, Subir Ray1, Kingshuk Bhattacharjee3. Abstract.10th International Conference on Advanced Technologies & Treatments for Paris, 2017
  • Observational study of Saroglitazar on Metabolic Parameters in Indian patients with Diabetic Dyslipidemia –A 43 weeks’ of Clinical Experience  Sanjay Chatterjee1, Subir Ray1, Anirban Majumder2. Abstract.10th International Conference on Advanced Technologies & Treatments for Paris, 2017
  • Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE study)
  • Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region (AP-JD)
  • IMPROVE™ Observational Study of Biphasic Insulin Aspart 30/70 in Patients with Type 2 Diabetes Mellitus
  •  A Randomized, Double Blind, Double Dummy, Comparative, Prospective, Multicenter, Parallel Study to assess Efficacy, Safety and Tolerability of Fixed Dose Combination of Teneligliptin and Metformin Tablet Compared with Metformin monotherapy in Adult Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Alone.
  • A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab (MGA031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
  • Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients (RECOMMEND)
  • Measurement Of AVSCD Risk parameters in Indian patients Eligible for statin therapy.(MORE study)
  • Long term prognostic risk of coronary heart disease & sroke in type 2 diabetes patients in India study.(LEGACY study).
  • ALS (Advanced Life Support Skills)- Certificate holder from Resuscitation Council, UK 
  • Communication Skill Certificate- from Medical Defense Union,UK 
  • Management and Leadership Certificate- From University of Newcastle,UK
  • He is a keen academician and researcher. He has been involved as a principle investigator in multiple clinical trials. He has delivered more than 100 lectures in as many CMEs both in India and abroad .He has chaired many academic sessions in CMEs held in India and abroad.
  • He is currently the honorary joint secretary of executive council member of Integrated Diabetes & Endocrine Academy, Kolkata.
  • He is a member of the association of clinical endocrinologist(USA)
  • He is a life member of Endocrine Society of India.